In conclusion, CDCA8 is functionally involved in HCC survival and CSC-like phenotype maintenance, suggesting that molecular targeting of CDCA8 may be an effective systemic therapy for the prevention of tumor recurrence via the elimination of both cancer cells and cancer stem cells in the liver tumor microenvironment. Here, CDCA8 is linked to hepatocellular carcinoma.